Johnson & Johnson Announces Dividend Increase of 5.6%


2019-04-26 08:00:00 PR Newswire


 Johnson & Johnson today announced that its Board of Directors has declared a 5.6% increase in the quarterly dividend rate, from $0.90 per share to $0.95 per share.  The increase was announced this morning at the Annual Meeting of Shareholders in New Brunswick, N.J. "In recognition of our 2018 results, strong financial position and confidence in the future of Johnson & Johnson, the Board has voted to increase the quarterly dividend for the 57th consecutive year," said Alex Gorsky, Chairman and Chief Executive Officer of the company. At the new rate, the indicated dividend on an annual basis is $3.80 per share compared to the previous rate of $3.60 per share.  The next quarterly dividend is payable on June 11, 2019 to shareholders of record as of the close of business on May 28, 2019. The ex-dividend date is May 24, 2019. About Johnson & Johnson At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That's why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world's largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.     
强生公司今天宣布,其董事会宣布将季度股息率提高5.6%,从每股0.90美元提高到每股0.95美元。今天上午在新泽西州新不伦瑞克市举行的年度股东大会上宣布了这一增加。 “鉴于我们2018年的业绩、强劲的财务状况以及对强生未来的信心,董事会已投票决定连续第57年增加季度股息,”该公司董事长兼首席执行官 Alex Gorsky 表示。 按新利率计算,所示股息按年计算为每股3.80美元,而先前为每股3.60美元。下一季度股息于2019年6月11日向截至2019年5月28日收市时登记在册的股东派发。除息日为2019年5月24日。 关于强生公司 在强生,我们相信良好的健康是充满活力的生活、繁荣的社区和进步的基础。这就是为什么130多年来,我们一直致力于让人们在每一个年龄和每一个生活阶段都保持良好。今天,作为世界上最大和最基础广泛的医疗保健公司,我们致力于利用我们的覆盖面和规模为好。我们努力提高获得和负担能力,创造更健康的社区,并把健康的思想、身体和环境置于每个人都能接触到的地方。我们正在融合我们的心、科学和聪明才智,深刻改变人类健康的轨迹。